Company Overview of TELA Bio, Inc.
TELA Bio, Inc. operates in healthcare industry focusing on biotechnology business. The company was founded in 2012 and is based in Malvern, Pennsylvania.
1 Great Valley Parkway
Malvern, PA 19355
Founded in 2012
Key Executives for TELA Bio, Inc.
President and Chief Executive Officer
Compensation as of Fiscal Year 2016.
TELA Bio, Inc. Key Developments
TELA Bio, Inc. Announces Settlement of Litigation with LifeCell
Nov 21 16
TELA Bio, Inc. announced that it has settled all litigations and disputes between TELA Bio and LifeCell, and that all pending state and federal court actions between the two companies have been dismissed. The settlement will allow TELA Bio to continue to manufacture and sell its OviTex ortfolio of products for use in ventral hernia repair and abdominal wall reconstruction, including a hydrated version of OviTex.
TELA Bio, Inc. Presents at 2016 Canaccord Genuity Medical Technology & Diagnostics Forum, Nov-17-2016 10:20 AM
Nov 3 16
TELA Bio, Inc. Presents at 2016 Canaccord Genuity Medical Technology & Diagnostics Forum, Nov-17-2016 10:20 AM. Venue: Westin Grand Central, 212 East 42nd Street, New York, New York, United States. Speakers: Antony Koblish, President and Chief Executive Officer.
TELA Bio, Inc. Announces OviTex Reinforced BioScaffolds Implanted in 100 Hernia Repair Procedures
Nov 1 16
TELA Bio, Inc. announced the company's OviTex RBSs have been implanted in more than 100 hernia repair procedures since receiving U.S. Food and Drug Administration (FDA) 510(k) clearance in June 2016. Surgical mesh reinforces soft tissue to improve long-term recurrence rates following hernia repair procedures. Previously, surgeons had to choose between biologic meshes that remodel into a patient's natural tissue, or synthetic meshes that provide strength but introduce a foreign body that results in prolonged inflammation in patients. OviTex RBSs integrate an embedded polymer and an intact extracellular matrix (ECM), a biologic building block derived from ovine rumen, in layered constructs designed for multi-directional cell repopulation and healthy tissue remodeling. The OviTex portfolio includes six products that are available with either permanent (polypropylene) polymer or resorbable (polyglycolic acid) polymer reinforcement.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries